Citation Impact

Citing Papers

Imbalance between neuroexcitatory and neuroinhibitory amino acids causes craving for ethanol
2004
Assessment and Clinical Relevance of Non-Fasting and Postprandial Triglycerides: An Expert Panel Statement
2011
Acamprosate and naltrexone treatment for alcohol dependence: an evidence-based risk-benefits assessment
2003
Alcohol and public health
2005 Standout
Update on neuropharmacological treatments for alcoholism: Scientific basis and clinical findings
2007
Prevalence, Correlates, Disability, and Comorbidity of DSM-IV Alcohol Abuse and Dependence in the United States
2007 Standout
Fibrates, dyslipoproteinaemia and cardiovascular disease
1999
Emerging drugs to treat alcoholism
2010
Transitions In and Out of Alcohol Use Disorders: Their Associations with Conditional Changes in Quality of Life Over a 3-Year Follow-Up Interval
2008
Neuroprotective and Abstinence-Promoting Effects of Acamprosate
2005
The Mesolimbic Dopamine Reward Circuit in Depression
2006 Standout
Analyzing milestones in smoking cessation: Illustration in a nicotine patch trial in adult smokers.
2006
Acoustic radiation force impulse elastography for differentiation of benign and malignant thyroid nodules with concurrent Hashimoto’s thyroiditis
2015
Imaginary Relish and Exquisite Torture: The Elaborated Intrusion Theory of Desire.
2005 Standout
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
Hyperthyroidism
2016
The Efficacy of Acamprosate in the Maintenance of Abstinence in Alcohol‐Dependent Individuals: Results of a Meta‐Analysis
2004
Neurocircuitry of Addiction
2009 Standout
Neurobiology of addiction: a neurocircuitry analysis
2016 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Neuroendocrine pathways of addictive behaviour
2004
Neuroendocrine pathways of addictive behaviour
2004
Nicotine replacement therapy for smoking cessation
2012 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Epidemiology ofDSM-5Alcohol Use Disorder
2015 Standout
Acamprosate for alcohol dependence
2010
American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules - 2016 Update Appendix
2016 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
2015 Standout
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.
1998 Standout
Industry sponsorship and research outcome
2017 Standout

Works of F. Landron being referenced

The European NEAT program: an integrated approach using acamprosate and psychosocial support for the prevention of relapse in alcohol-dependent patients with a statistical modeling of therapy success prediction.
2002
Improvement in Quality of Life After Treatment for Alcohol Dependence With Acamprosate and Psychosocial Support
2004
Pharmacodynamic Effects of Acamprosate on Markers of Cerebral Function in Alcohol-Dependent Subjects Administered as Pretreatment and during Alcohol Abstinence
2004
Post‐prandial metabolism of triglyceride‐rich lipoproteins in non‐insulin‐dependent diabetic patients before and after bezafibrate treatment
1997
An observational study of the initial management of hypothyroidism in France: the ORCHIDEE study
2012
The European NEAT Program: An Integrated Approach Using Acamprosate and Psychosocial Support for the Prevention of Relapse in Alcohol‐Dependent Patients With a Statistical Modeling of Therapy Success Prediction
2002
Does Acamprosate Improve Reduction of Drinking As Well As Aiding Abstinence?
2003
Clinical presentation of hyperthyroidism in a large representative sample of outpatients in France: relationships with age, aetiology and hormonal parameters
2015
Rankless by CCL
2026